Market Cap

Horizon Therapeutics Public Limited Company Market Capitalization:

$26.63 Billion

USD as of Jan. 1, 2025

business Horizon Therapeutics Public Limited Company Company Profile

Horizon Therapeutics Public Limited Company Main Stock Listing

NASDAQ: HZNP

Market Capitalization History of Horizon Therapeutics Public Limited Company

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Roche $260.54 B
Novartis $243.50 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Horizon Therapeutics Public Limited Company market cap

Date Market Cap YoY Change
Jan. 1, 2025 $26.63 B 3.62%
Jan. 1, 2023 $25.70 B 21.30%
Jan. 1, 2022 $21.19 B 28.77%
Jan. 1, 2021 $16.45 B 110.15%
Jan. 1, 2020 $7.83 B 60.49%
Jan. 1, 2019 $4.88 B 47.70%
Jan. 1, 2018 $3.30 B -11.12%
Jan. 1, 2017 $3.72 B -6.46%
Jan. 1, 2016 $3.97 B 6.51%
Jan. 1, 2015 $3.73 B 66.63%
Jan. 1, 2014 $2.24 B 362.91%
Jan. 1, 2013 $483.6 M -46.35%
Jan. 1, 2012 $901.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Horizon Therapeutics Public Limited Company Categories

Ireland languages Healthcare languages Drug Manufacturers—General
Ireland Healthcare Ireland Drug Manufacturers—General

Stocks & Indices

Horizon Therapeutics Public Limited Company has the following listings and related stock indices.


Stock: NASDAQ: HZNP

Stock: FSX: HPR

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.